Glen Harbor Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $397K | Sell |
4,048
-272
| -6% | -$26.7K | 0.01% | 782 |
|
|
2019
Q2 | $566K | Sell |
4,320
-1,472
| -25% | -$193K | 0.01% | 669 |
|
|
2019
Q1 | $783K | Buy |
5,792
+1,424
| +33% | +$193K | 0.02% | 516 |
|
|
2018
Q4 | $425K | Sell |
4,368
-80
| -2% | -$7.78K | 0.01% | 682 |
|
|
2018
Q3 | $618K | Buy |
4,448
+48
| +1% | +$6.67K | 0.01% | 630 |
|
|
2018
Q2 | $546K | Buy |
4,400
+592
| +16% | +$73.5K | 0.01% | 615 |
|
|
2018
Q1 | $424K | Sell |
3,808
-160
| -4% | -$17.8K | 0.01% | 699 |
|
|
2017
Q4 | $475K | Buy |
3,968
+1,104
| +39% | +$132K | 0.01% | 659 |
|
|
2017
Q3 | $402K | Sell |
2,864
-512
| -15% | -$71.9K | 0.01% | 663 |
|
|
2017
Q2 | $411K | Buy |
3,376
+272
| +9% | +$33.1K | 0.01% | 646 |
|
|
2017
Q1 | $376K | Buy |
3,104
+480
| +18% | +$58.1K | 0.01% | 624 |
|
|
2016
Q4 | $321K | Buy |
+2,624
| New | +$321K | 0.01% | 608 |
|